Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-04-26 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
中国银河证券股份有限公司关于公司向特定对象发行股票之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled '上市保荐书' which translates to 'Listing Sponsorship Letter' or 'Sponsorship Document for Stock Issuance'. It is issued by China Galaxy Securities as the sponsor for Tianjin Ringpu Biotechnology Co., Ltd. regarding a specific stock issuance to particular investors. The document contains detailed information about the issuer, business operations, core technologies, financial data, risk factors, and regulatory compliance related to the stock issuance. It is a comprehensive sponsorship report related to a capital raising event through a private placement of shares. This type of document is typically classified under Capital/Financing Update (CAP) as it relates to updates on company fundraising and capital structure changes. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement. Therefore, the appropriate classification is CAP with high confidence.
2021-04-26 Chinese
关于向特定对象发行股票申请获得深圳证券交易所受理的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (545 characters) regarding the acceptance by the Shenzhen Stock Exchange of the company's application for a private placement of shares. It mentions the review and acceptance of application documents but does not contain financial statements or detailed financial data. It is an update on a capital raising process, specifically about the acceptance of the application for a share issuance to specific investors. This fits the category of Capital/Financing Update (CAP). The document is not a full report but an announcement about a financing step.
2021-04-26 Chinese
关于公司向广州市华南农大生物药品有限公司增资实施募集资金投资项目暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding an increase in capital investment into its controlled subsidiary Guangzhou South China Agricultural University Biopharmaceutical Co., Ltd. It details the board meeting resolutions, the nature of the related party transaction, the investment purpose, risks, and independent directors' opinions. The document is a formal disclosure about a capital increase transaction using raised funds, including details on the pricing policy, shareholder structure, and compliance with regulatory requirements. It does not contain financial statements or comprehensive financial data, nor is it a report or transcript. It is a regulatory announcement about a capital/financing update related to the company's fundraising and investment activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters but contains substantive information about the capital increase transaction, not merely a report publication announcement or a brief notice.
2021-04-21 Chinese
关于调整公司2021年度向特定对象发行股票方案的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding adjustments to a specific stock issuance plan for the year 2021 by Tianjin Ruipu Biotechnology Co., Ltd. It discusses changes in the number of shares to be issued to specific investors and references approvals by the board and shareholders. The document does not contain financial statements or detailed financial data but rather focuses on the update of a capital raising plan and related regulatory approvals. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is short and it is not a report publication announcement or a certification. Therefore, the appropriate classification is CAP with high confidence.
2021-04-21 Chinese
关于公司向湖南中岸生物药业有限公司通过增资以及委托贷款方式实施募集资金投资项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Tianjin Ruipu Biological Technology Co., Ltd. regarding an investment project involving capital increase and entrusted loans to its subsidiary Hunan Zhong'an Biopharmaceutical Co., Ltd. It details the board meeting resolutions, investment amounts, valuation reports, shareholder structure changes, and approvals by the board, independent directors, and supervisory board. The document is a formal disclosure of a capital/financing update related to the company's fundraising and investment activities. It does not contain comprehensive financial statements or quarterly/yearly financial results, nor is it a report or transcript. The document length is about 5,447 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-04-21 Chinese
关于召开2021年第一次临时股东大会的公告
AGM Information Classification · 95% confidence The document is a notice for convening the 2021 first extraordinary general meeting of shareholders of Tianjin Ruipu Biotechnology Co., Ltd. It includes details about the meeting time, location, agenda, voting procedures, and registration methods. It does not contain financial statements or results but is an announcement related to a shareholders' meeting. The document length is under 5,000 characters and primarily serves to notify shareholders about the meeting and voting process. Therefore, it fits the category of AGM Information (AGM-R) rather than the actual meeting minutes or results.
2021-04-21 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.